Medicare Enrolled

Dr. Antonio Vazquez-Diaz, MD

Pediatric Adolescent Medicine · Orlando, FL
100 W GORE ST STE 600, Orlando, FL 32806
3218426671
Registered in NPPES since 2007
NPI: 1578613022 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vazquez-Diaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vazquez-Diaz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vazquez-Diaz

Dr. Antonio Vazquez-Diaz is a pediatric adolescent medicine specialist in Orlando, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Vazquez-Diaz received a total of $6,178 from 40 pharmaceutical and/or device companies across 211 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vazquez-Diaz is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $6,178 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 114935 Clear January 31, 2027 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$6,178
Total received (2018-2024)
Avg $883/year across 7 years
Top 1% in FL for pediatric adolescent medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
211
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$554
2023
$852
2022
$964
2021
$1,187
2020
$315
2019
$652
2018
$1,654

Payments by company (2024)

NEUROPACE, INC.
$176
BioMarin Pharmaceutical Inc.
$108
BIOCODEX, INC.
$80
CATALYST PHARMACEUTICALS, INC.
$52
ACADIA Pharmaceuticals Inc
$50
Neurelis, Inc.
$46
JAZZ PHARMACEUTICALS INC.
$21
Marinus Pharmaceuticals, Inc.
$20
Top 3 companies account for 65.8% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$1,620
Sunovion Pharmaceuticals Inc.
$544
Ipsen Biopharmaceuticals, Inc
$376
NEUROPACE, INC.
$339
UCB, Inc.
$333
Eisai Inc.
$323
BioMarin Pharmaceutical Inc.
$237
SK Life Science, Inc.
$228
LivaNova USA, Inc.
$193
JAZZ PHARMACEUTICALS INC.
$185
Sumitomo Pharma America, Inc.
$161
Neurelis, Inc.
$160
AQUESTIVE THERAPEUTICS, INC.
$153
Shire North American Group Inc
$146
Takeda Pharmaceuticals U.S.A., Inc.
$110
PTC Therapeutics, Inc.
$109
Corium, LLC
$88
Novartis Pharmaceuticals Corporation
$86
BIOCODEX, INC.
$80
Marinus Pharmaceuticals, Inc.
$67
EISAI INC.
$63
Ironshore Pharmaceuticals Inc.
$55
Greenwich Biosciences, Inc.
$53
CATALYST PHARMACEUTICALS, INC.
$52
Travere Therapeutics, Inc.
$51
Tris Pharma Inc
$51
ACADIA Pharmaceuticals Inc
$50
Azurity Pharmaceuticals, Inc.
$48
AbbVie Inc.
$32
NOVARTIS PHARMACEUTICALS CORPORATION
$20
Biohaven Pharmaceutical Holding Company Ltd.
$19
Amneal Pharmaceuticals LLC
$19
Upsher-Smith Laboratories LLC
$18
Retrophin, Inc.
$18
NS Pharma, Inc.
$18
Lundbeck LLC
$18
Allergan, Inc.
$17
Neurocrine Biosciences, Inc.
$15
ABBVIE INC.
$14
Biohaven Pharmaceuticals, Inc.
$13
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · AFINITOR · APTIOM · Azstarys · BOTOX · Brineura · Briviact · Cholbam · DAYBUE · DIACOMIT · DYSPORT · Dyanavel XR · Dysport · EMFLAZA · EPIDIOLEX · Epidiolex · Eprontia · FYCOMPA · Fintepla · Fycompa · INGREZZA · JORNAY PM · LYVISPAH · MYDAYIS · NURTEC ODT · ONFI · OXTELLAR XR · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Quillivant XR · RNS Neurostimulator Kit · SYMPAZAN · TRINTELLIX · TROKENDI XR · VALTOCO · VILTEPSO · VNS Therapy SenTiva Model 1000 Generator · VYVANSE · Vimpat · XCOPRI · XYWAV · ZTALMY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric adolescent medicine specialist in Orlando?
Compare pediatric adolescent medicines in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse pediatric adolescent medicines nearby

Geographic Context

Pediatric adolescent medicines in nearby ZIP areas
17
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vazquez-Diaz is a pediatric adolescent medicine specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Vazquez-Diaz receive payments from pharmaceutical companies?
Yes. Dr. Vazquez-Diaz received a total of $6,178 from 40 companies across 211 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Vazquez-Diaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Adolescent Medicines in Orlando
Browse pediatric adolescent medicines in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Adolescent Medicines in FL
Pediatric adolescent medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Adolescent Medicines in FL
Which FL pediatric adolescent medicines receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →